A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.
- DOI
- 10.1038/s41591-025-04154-z
- Published
- 2026 Feb
- Container
- Nature medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-025-04154-z,
title = {A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.},
author = {Erritzoe D and Barba T and Benway T and Joel Z and Good M and Layzell M and Jones MB and Campbell G and Murphy-Beiner A and Rands P and Boyce M and Topping H and Weiss B and Timmermann C and Nutt D and Carhart-Harris R and Routledge C and James E},
year = {2026},
journal = {Nature medicine},
doi = {10.1038/s41591-025-04154-z},
url = {https://doi.org/10.1038/s41591-025-04154-z}
}RIS
TY - JOUR TI - A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial. AU - Erritzoe D AU - Barba T AU - Benway T AU - Joel Z AU - Good M AU - Layzell M AU - Jones MB AU - Campbell G AU - Murphy-Beiner A AU - Rands P AU - Boyce M AU - Topping H AU - Weiss B AU - Timmermann C AU - Nutt D AU - Carhart-Harris R AU - Routledge C AU - James E PY - 2026 JO - Nature medicine DO - 10.1038/s41591-025-04154-z UR - https://doi.org/10.1038/s41591-025-04154-z ER -
APA
D, E., T, B., T, B., Z, J., M, G., M, L., MB, J., G, C., A, M., P, R., M, B., H, T., B, W., C, T., D, N., R, C., C, R., & E, J. (2026). A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.. Nature medicine. https://doi.org/10.1038/s41591-025-04154-z
Source records
- pubmed · retrieved 2026-09-26T00:01:38.302Z